Inactive Instrument

News Aralez Pharmaceuticals Inc Nasdaq

Equities

CA03852X1006

End-of-day quote Nasdaq Other stock markets
-	-

2019	Old API Wind-Down Ltd. Announces Management Changes	CI
2019	Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Old API Wind-Down Ltd. Announces Management Changes	30/05/19	CI
Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd	06/02/19	CI
Aralez Pharmaceuticals Inc. Announces Management Changes	18/01/19	CI
Nuvo Pharmaceuticals Inc. completed the acquisition of Aralez Pharmaceuticals Canada Inc. from Aralez Pharmaceuticals Inc..	30/12/18	CI
Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from NASDAQ Composite Index	20/08/18	CI
Aralez Pharmaceuticals Inc. Announces the Resignation of Seth A. Rudnick, Neal F. Fowler and Rob Harris as Directors	14/08/18	CI
Nuvo Pharmaceuticals Inc. signed a letter of intent to acquire Aralez Pharmaceuticals Canada Inc. from Aralez Pharmaceuticals Inc. for $62.5 million.	09/08/18	CI
Aralez Pharmaceuticals Inc. Announces Resignation of James Tursi as Chief Medical Officer, Effective from August 2, 2018	26/07/18	CI
Aralez Pharmaceuticals Inc. Enters into an Amendment to that Certain Second Amended and Restated Facility Agreement with Deerfield Partners, L.P	29/06/18	CI
Transcript : Aralez Pharmaceuticals Inc., Q1 2018 Earnings Call, May 08, 2018	08/05/18
Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018	08/05/18	CI
Aralez Pharmaceuticals Inc. Announces Resignation of Mark Glickman as Chief Commercial Officer, Effective on March 30, 2018	21/03/18	CI
Aralez Pharmaceuticals Inc. Appoints Michael Kaseta as Chief Financial Officer	14/03/18	CI
Transcript : Aralez Pharmaceuticals Inc., Q4 2017 Earnings Call, Mar 13, 2018	13/03/18
Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year 2018	13/03/18	CI
Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from NASDAQ Biotechnology Index	15/12/17	CI
Aralez Pharmaceuticals Inc. Announces Executive Changes	30/11/17	CI
Transcript : Aralez Pharmaceuticals Inc., Q3 2017 Earnings Call, Nov 09, 2017	09/11/17
Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Revises Earnings Guidance for the Year Ending December 31, 2017 and provides Preliminary Guidance for Full Year Ending December 31, 2018	09/11/17	CI
Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from S&P Global BMI Index	18/09/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aralez Pharmaceuticals Inc Nasdaq

Equities

CA03852X1006

Summary

Filters